Estrella Immunopharma, Inc. (ESLA)

NASDAQ: ESLA · IEX Real-Time Price · USD

1.052

+0.002 (0.19%)

At close: May 2, 2024, 2:56 PM

1.010

-0.042 (-3.99%)

After-hours: May 2, 2024, 7:22 PM EDT

Estrella Immunopharma Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022
Net Income	-11.11	-1
Share-Based Compensation	0.41	0
Other Operating Activities	9.37	-0.05
Operating Cash Flow	-1.34	-1.04
Acquisitions	-0.27	0
Change in Investments	0	36.17
Investing Cash Flow	-0.27	36.17
Share Issuance / Repurchase	0	-36.11
Debt Issued / Paid	0	0.55
Financing Cash Flow	0	-35.56
Net Cash Flow	-1.61	-0.44
Free Cash Flow	-1.34	-1.04
Free Cash Flow Per Share	-1.05	-0.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).